Bioavailability of three novel oral, sustained‐release pellets, relative to an immediate‐release tablet containing 500 mg flucytosine: A randomized, open‐label, crossover study in healthy volunteersVishal Goyal, Isabela Ribeiro, Johanna Eriksson et al.|Clinical and Translational Science|2024Cited by 4
Bioavailability of a novel sustained‐release pellet formulation of 5‐flucytosine in healthy‐fed participants for use in patients with cryptococcal meningitisNabila Ibnou Zekri Lassout, Isabela Ribeiro, Vishal Goyal et al.|Clinical and Translational Science|2024Cited by 2